340 related articles for article (PubMed ID: 15641051)
1. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
[TBL] [Abstract][Full Text] [Related]
2. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
[TBL] [Abstract][Full Text] [Related]
3. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
Matthews V; Schuster B; Schütze S; Bussmeyer I; Ludwig A; Hundhausen C; Sadowski T; Saftig P; Hartmann D; Kallen KJ; Rose-John S
J Biol Chem; 2003 Oct; 278(40):38829-39. PubMed ID: 12832423
[TBL] [Abstract][Full Text] [Related]
4. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
Vermes C; Jacobs JJ; Zhang J; Firneisz G; Roebuck KA; Glant TT
J Biol Chem; 2002 May; 277(19):16879-87. PubMed ID: 11884403
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
Franchimont N; Durant D; Canalis E
Endocrinology; 1997 Aug; 138(8):3380-6. PubMed ID: 9231791
[TBL] [Abstract][Full Text] [Related]
6. Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells.
Campard D; Vasse M; Rose-John S; Poyer F; Lamacz M; Vannier JP
Stem Cells; 2006 May; 24(5):1302-14. PubMed ID: 16357344
[TBL] [Abstract][Full Text] [Related]
7. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17).
Budagian V; Bulanova E; Orinska Z; Ludwig A; Rose-John S; Saftig P; Borden EC; Bulfone-Paus S
J Biol Chem; 2004 Sep; 279(39):40368-75. PubMed ID: 15215246
[TBL] [Abstract][Full Text] [Related]
8. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
10. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
12. Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.
Arnold P; Boll I; Rothaug M; Schumacher N; Schmidt F; Wichert R; Schneppenheim J; Lokau J; Pickhinke U; Koudelka T; Tholey A; Rabe B; Scheller J; Lucius R; Garbers C; Rose-John S; Becker-Pauly C
Sci Rep; 2017 Mar; 7():44053. PubMed ID: 28276471
[TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
14. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
[TBL] [Abstract][Full Text] [Related]
15. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.
Kurozumi A; Nakano K; Yamagata K; Okada Y; Nakayamada S; Tanaka Y
Bone; 2019 Jul; 124():53-61. PubMed ID: 30981888
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.
Horiuchi S; Yamamoto N; Dewan MZ; Takahashi Y; Yamashita A; Yoshida T; Nowell MA; Richards PJ; Jones SA; Yamamoto N
Int J Cancer; 2006 Aug; 119(4):823-30. PubMed ID: 16557588
[TBL] [Abstract][Full Text] [Related]
17. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
[TBL] [Abstract][Full Text] [Related]
18. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of TNF-alpha, TACE, furin, IL-1beta and matrilysin in UVA- and UVB-irradiated HaCat cells.
Skiba B; Neill B; Piva TJ
Photodermatol Photoimmunol Photomed; 2005 Aug; 21(4):173-82. PubMed ID: 15998365
[TBL] [Abstract][Full Text] [Related]
20. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
